MEXICO CITY, Mexico, August 5 /PRNewswire/ --

- Ninety-Six-Week Data on Tibotec Investigational NNRTI Presented at AIDS 2008

New phase IIb data from Tibotec Pharmaceuticals Ltd. show that TMC278, the company's once-daily, investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), provides long-term efficacy and tolerability in treatment-naïve adults with HIV. Ninety-six-week study results showed that more than 70 percent of patients receiving TMC278, plus a background regimen, achieved a confirmed and sustained undetectable viral load (defined as < 50 HIV RNA copies/mL). These findings were presented today at the International AIDS Conference (AIDS 2008) in Mexico City.

REHOVOT, Israel, August 5 /PRNewswire/ --

- New Online Home For 3-D Printing Innovator

Objet Geometries Ltd., the innovation leader in 3-D printing, today announced that the company has moved its Web site to a new domain name, http://www.objet.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080514/305187 )

"Our acquisition of this domain name represents a significant step forward for our branding and digital communications efforts," said Adina Shorr, CEO of Objet Geometries. "From now on, http://www.objet.com will be the new online destination for the latest innovations in 3-D printing, and we look forward to welcoming even more visitors to learn more about our groundbreaking systems and materails."

TEL AVIV, Israel, BADAJOZ, Spain and SINGAPORE, August 5 /PRNewswire/ -- Pollogen Ltd. announced that Ms. Yfat Scialom has been appointed as the new Chief Executive Officer effective July 20, 2008.

Ms. Scialom comes to Pollogen with 20 years of experience in sales, marketing and senior management in the medical and aesthetic field. She previously served as VP of Marketing and Sales at UltraShape Ltd., a leader in non-invasive body contouring solutions. Ms. Scialom established the marketing and sales infrastructure and was responsible for the successful launch of the Company's products, defining the branding, positioning, and the formation of a global distribution network in 50 countries and 3 direct subsidiaries, driving sales from zero to tens of millions of dollars.

You are a coach, trying to juggle practice plans, meetings, game prep and player issues while trying to stay focused on the season's goals.  At the end of another long day, you see this in your inbox:

MEMO
To:         All Head Coaches
From:     Athletic Director
Subject:  Monthly Reading List to Keep Up with Current Sport Science Research 
-  Neuromuscular Activation of Triceps Surae Using Muscle Functional MRI and EMG
-  Positive effects of intermittent hypoxia (live high:train low) on exercise performance are not mediated primarily by augmented red cell volume
-  Physiologic Left Ventricular Cavity Dilatation in Elite Athletes
-  The Relationships of Perceived Motivational Climate to Cohesion and Collective Efficacy in Elite Female Teams

Just some light reading before bedtime...  This is an obvious exaggeration of the gap between sport science researchers and practitioners.  While those are actual research paper titles from the last few years under the heading of "sport science", the intended audience was most likely not coaches or athletes, but rather fellow academic peers.  The real question is whether the important conclusions and knowledge captured in all of this research is ever actually used to improve athletic performance?  How can a coach or athlete understand, combine and transfer this information into their game?

LONDON, August 5 /PRNewswire/ --

Planalytics Inc., the global leader in Business Weather Intelligence(R), explained in its July WeatherCall(SM) report that a split in temperature patterns caused a jolt to consumer behavior. The month started off cool and wet and stayed that way until around the 23rd of July. Initially, summer purchases were slow, causing many retailers to respond by discounting their warm weather items. The last third of July resulted in a burst of warmth throughout the country. The rise in temperature was welcomed by the high street as many consumers were purchasing T-shirts and shorts that were slow to leave shelves at the start of the month.

SAN FRANCISCO, August 5 /PRNewswire/ --

Oncology NEWS International, a leading provider of news and coverage of the hematology and oncology market for the past 17 years, has announced a redesign of its editorial content aimed at addressing the ever-changing needs of the cancer care market.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080805/AQTU031)

Effective immediately, readers of Oncology NEWS International will notice a more functional and more appealing format that showcases broader coverage and better represents the readers in the oncology and hematology community.

HILVERSUM, The Netherlands, August 5 /PRNewswire/ --

- Wireless Range and Amplifier Design Innovations Deliver State of the Art Multi-Room Music Experience

Sonos(R), Inc., the leading developer of wireless multi-room music systems for the home, today introduced two new ZonePlayers to deliver a state-of-the-art multi-room music experience. With innovations in both wireless technology and amplifier design, the Sonos ZonePlayer 120 (ZP120) and the Sonos ZonePlayer 90 (ZP90) make Sonos the ideal system for music lovers who want to enjoy all the music they love, all over the house. The new ZonePlayers are available starting today at all Sonos authorised retailers and at www.sonos.com.

Today epigenetics is all the rage, but it has its roots in a pair of papers that appeared nearly simultaneously in 1952-1953.

Luria SE and Human ML. 1952. A nonhereditary, host-induced variation of bacterial viruses. J. Bact. 64: 557-569 and also Bertani G and Weigle JJ. 1953. Host controlled variation in bacterial viruses. J. Bact. 65: 113-121. 

Luria & Human and Bertani & Weigle independently discovered that bacterial hosts can affect the growth and phenotypic properties of their bacteriophages.

SAN JOSE, California, August 5 /PRNewswire/ --

- New 1U Chassis and SuperServers with up to 8 Hot-Swap 2.5" Hard Drives Demonstrated at LinuxWorld 2008

Super Micro Computer, Inc. (Nasdaq: SMCI), a leader in application-optimized, high performance server solutions, today announced volume shipments of the industry's first and only 1U chassis and servers with up to 90%+ power efficiency. Continuing its technology and design leadership, the company has launched three new 1U chassis and SuperServers featuring the first 80 Plus Silver-certified power supply for 1U systems, which will be on display at LinuxWorld 2008 in San Francisco, August 5-7, booth #1125.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080805/AQTU077)

HALIFAX, Canada, August 5 /PRNewswire/ -- ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, today announced receipt of patent approval from the Japanese Patent Office for its vaccine platform. The specific patent, Vaccines with enhanced immune response and methods for their preparation, claims broad exclusivity that an effective, long-term immune response to treat a disease can be produced using a vaccine comprising of an antigen, an adjuvant, vesicles known as liposomes, and a hydrophobic carrier.

"We have a novel technology that enhances vaccines dramatically, so receiving patent approval is important in protecting our competitive advantage," commented Dr. Marc Mansour, Vice President R&D at IVT.